We developed a large-scale single-cell intrinsic morphological profiling strategy using ultrahigh-throughput quantitative phase imaging (QPI) combined with a novel spinning on-the-fly cell-based assay platform. This integrated system demonstrates the unprecedented functional assay capability of QPI in not only scaling up the assay throughput, but also empowering new cytometric power to perform multiplexed live-cell drug screening (96 conditions in a single run) and genetic perturbation assay (by CRISPR). This platform thus allows generation of large cellular QPI datasets (4.85 TByte in this study) that could spearhead cost-effective label-free solutions for identifying disease-or gene-related cellular morphological phenotypes in therapeutics screening.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.